Peptidergic mechanisms in the pancreasHOLST, J. J.Archives internationales de pharmacodynamie et de thérapie. 1990, Vol 303, pp 252-269, issn 0003-9780, 18 p.Conference Paper

Peptidergic innervation of the Langerhans' organHOLST, J. J.Frontiers of hormone research. 1987, Vol 16, pp 15-20, issn 0301-3073Article

Glucagon-like peptide-1 : from extract to agent. the claude bernard lecture, 2005HOLST, J. J.Diabetologia (Berlin). 2006, Vol 49, Num 2, pp 253-260, issn 0012-186X, 8 p.Article

Glucagon-like peptide 1 (GLP-1) : An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potentialHOLST, J. J.Trends in endocrinology and metabolism. 1999, Vol 10, Num 6, pp 229-235, issn 1043-2760Article

EnteroglucagonHOLST, J. J.Advances in metabolic disorders. 1988, Vol 11, pp 393-419, issn 0065-2903Article

Incretin hormones and the satiation signalHOLST, J. J.International journal of obesity. 2013, Vol 37, Num 9, pp 1161-1168, issn 0307-0565, 8 p.Article

Does the endocrine secretion of the pancreas exert a local control of the exocrine secretion?HOLST, J. J.Pancreas. 1987, Vol 2, Num 5, pp 613-619, issn 0885-3177Article

Circulating galanin : origin, metabolism, and phrmacokinetics in anesthetized pigsHARLING, H; HOLST, J. J.American journal of physiology. Endocrinology and metabolism. 1992, Vol 25, Num 1, pp E52-E57, issn 0193-1849Article

GLP-1 : a humoral mediator of the ileal brake in humans ?LAYER, P; HOLST, J. J.Digestion. 1993, Vol 54, Num 6, pp 385-386, issn 0012-2823Conference Paper

Incretins, insulin secretion and Type 2 diabetes mellitusVILSBØLL, T; HOLST, J. J.Diabetologia (Berlin). 2004, Vol 47, Num 3, pp 357-366, issn 0012-186X, 10 p.Article

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antiseraKRARUP, T; HOLST, J. J.Regulatory peptides. 1984, Vol 9, Num 1-2, pp 35-46, issn 0167-0115Article

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetesHOLST, J. J; DEACON, C. F.Diabetes (New York, NY). 1998, Vol 47, Num 11, pp 1663-1670, issn 0012-1797Article

Role of nitric oxide in neurally induced pancreatic exocrine secretion in pigsHOLST, J. J; RASMUSSEN, T. N; SCHMIDT, P et al.American journal of physiology. Gastrointestinal and liver physiology. 1994, Vol 29, Num 2, pp G206-G213, issn 0193-1857Article

Release of immunoreactive somatostatin, vasoactive intestinal polypeptide (VIP), and galanin during propulsive complexes in isolated pig ileumSCHMIDT, P; RASMUSSEN, T. N; HOLST, J. J et al.Peptides (New York, NY. 1980). 1993, Vol 14, Num 2, pp 215-220, issn 0196-9781Article

Oxidation/reduction explains heterogeneity of pancreatic somatostatinBERSANI, M; JOHSEN, A. H; HOLST, J. J et al.FEBS letters. 1991, Vol 279, Num 2, pp 237-239, issn 0014-5793, 3 p.Article

Secretin uncouples glucose inhibition of glucagon-producing cells resulting in a simultaneous stimulation of both glucagon and insulin releaseKOFOD, H; HOLST, J. J; LERNMARK, A et al.Regulatory peptides. 1988, Vol 23, Num 3, pp 315-322, issn 0167-0115Article

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in miceREIMER, M. Kvist; HOLST, J. J; AHREN, B et al.European journal of endocrinology. 2002, Vol 146, Num 5, pp 717-727, issn 0804-4643Article

Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potentialHOLST, J. J.Current medicinal chemistry. 1999, Vol 6, Num 11, pp 1005-1017, issn 0929-8673Article

Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflowWETTERGREN, A; WØJDEMANN, M; HOLST, J. J et al.American journal of physiology. Gastrointestinal and liver physiology. 1998, Vol 38, Num 5, pp G984-G992, issn 0193-1857Article

Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy manSHALEV, A; HOLST, J. J; KELLER, U et al.European journal of clinical investigation. 1997, Vol 27, Num 1, pp 10-16, issn 0014-2972Article

All products of proglucagon are elevated in plasma from uremic patientsØRSKOV, C; ANDREASEN, J; HOLST, J. J et al.The Journal of clinical endocrinology and metabolism. 1992, Vol 74, Num 2, pp 379-384, issn 0021-972XArticle

Nervous control of the release of substance P and neurokinin A from the isolated perfused porcine ileumSCHMIDT, P; RASMUSSEN, T. N; HOLST, J. J et al.Journal of the autonomic nervous system. 1992, Vol 38, Num 2, pp 85-95, issn 0165-1838Article

On the contamination of commercially available aprotinins with pancreatic islet peptidesBALDISSERA, F. G. A; HOLST, J. J.Scandinavian journal of clinical & laboratory investigation. 1984, Vol 44, Num 7, pp 669-672, issn 0036-5513Article

Antidiabetogenic action of cholecystokinin-8 in type 2 diabetesAHREN, B; HOLST, J. J; EFENDIC, S et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 3, pp 1043-1048, issn 0021-972XArticle

PACAP contributes to insulin secretion after gastric glucose gavage in miceFILIPSSON, K; HOLST, J. J; AHREN, B et al.American journal of physiology. Regulatory, integrative and comparative physiology. 2000, Vol 48, Num 2, pp R424-R432, issn 0363-6119Article